March 21, 2025
Johnson & Johnson Neurovascular leader heads for the exit ~1 min.
Mark Dickinson, the leader of Johnson & Johnson Neurovascular, has announced his departure from the company....
March 20, 2025
Johnson & Johnson Faces Shareholder Activism Over Human Rights and Executive Pay Proposals ~2 min.
Mark Dickinson, the leader of Johnson & Johnson Neurovascular, is leaving the company, according to sources....
March 19, 2025
FDA Clears Johnson & Johnson Robot for Enhanced Bronchoscopy ~1 min.
Johnson & Johnson's MedTech division has received clearance from the FDA for its enhanced robotic-assisted bronchoscopy system....
March 18, 2025
Johnson & Johnson MedTech Introduces New EP Neurovascular Leader ~1 min.
Johnson & Johnson MedTech, a subsidiary of Johnson & Johnson, has appointed a new leader for its electrophysiology and neurovascular group....
March 14, 2025
Johnson & Johnson's Decades-Long Quest for Effective IBD Treatments ~1 min.
Johnson & Johnson has been investing in research and development for decades in order to find effective treatments for inflammatory bowel disease (IBD)....
February 28, 2025
Johnson & Johnson's Strong Performance Since Last Earnings Report Raises Expectations ~1 min.
Johnson & Johnson (JNJ) has shown an impressive 8.9% increase in its stock price since the release of its last earnings report....
February 26, 2025
The surgical devices I design for JJ speed healing and save lives ~1 min.
Johnson & Johnson (JNJ) has been at the forefront of medical technology, constantly innovating and developing breakthrough surgical devices that not only speed up the healing process but also save lives....
February 18, 2025
Johnson & Johnson reportedly wants to sell Cerenovus for 1B ~1 min.
According to recent reports, Johnson & Johnson is considering selling its Cerenovus stroke business for 1 billion dollars....
February 16, 2025
Johnson & Johnson Explores Sale of Cerenovus for $1 Billion ~1 min.
According to reports, pharmaceutical giant Johnson & Johnson is looking to sell its stroke care business, Cerenovus, for a staggering $1 billion....
February 14, 2025
Johnson & Johnson to Sell its Cerenovus Stroke Business for $1B ~2 min.
Johnson & Johnson, the multinational pharmaceutical company, is reportedly looking to sell its Cerenovus stroke care business for a sum of $1 billion....
